Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Our Process

  1. The Essential Evidence Editorial Team continuously reviews over 100 of the most important medical journals looking for articles that meet our criteria for relevance and validity. The list of journals used in this process is itself reviewed regularly to ensure our team always captures the most important and clinically relevant publications.
  2. Each article selected is critically appraised for relevance and validity. Relevant articles report patient-oriented outcomes such as morbidity, mortality, quality of life, or symptom improvement. For articles that meet both relevance and validity criteria, first POEM drafts are written by the Essential Evidence Editors.
  3. The first draft of every POEM is sent to the full Essential Evidence Editorial Team, as well as to our Editorial Board for review.
  4. Essential Evidence Editors then revise their POEMs based on collated feedback from the Editorial Team and Editorial Board.
  5. The final POEMs are edited for clarity, completeness, and style, and assigned a level of evidence.
  6. The POEMs are distributed globally as Daily POEMs Alerts to all POEM subscribers and added to the Essential Evidence Plus database.
  7. POEMs assessed as being particularly important to clinical practice by the Editorial Team are used to update Essential Evidence Topics immediately, while the remainder are used as part of the routine updating process.

A Note About Data

The numbers don't add up all the time. Daily POEMs are designed to be a synopsis, not a complete abstract. For these synopses we extract only the most important information. We generally don't report non-significant results (the actual numbers) or other information that is typically not of interest. This is why each review is supported by a Level of Evidence (LOE) indicator, allowing the reader to discern an overall sense of how well this new information is supported.

The Bottom Line

The most important nuggets are detailed in the Bottom Line, with additional information in the body of the Synopsis. Our research has shown that most people read the Bottom Line first and then the synopsis, but only if they are interested in knowing the details. In the Bottom Line, we occasionally refer to other studies and pull this particular study into context with other evidence so that users are aware of related existing studies.